MedTrace Logo

Rice Technologies for Cervical Cancer Screening and Diagnosis

NCT05372484 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 678

Last updated 2026-02-13

No results posted yet for this study

Summary

The study aims to compare the accuracy of the lateral flow test to detect HPV at the POC with commercially available HPV test and to determine the diagnostic accuracy and reliability of a multimodal optical imaging system to detect cervical dysplasia, with the gold reference standard of histopathology.

Conditions

Interventions

DEVICE

Multimodal optical imaging

Women referred for colposcopy due to abnormal cervical screening will be recruited into the experimental group of the study. Imaging of study participants will take place during the colposcopy examination.

Sponsors & Collaborators

  • Eduardo Mondlane University

    collaborator OTHER

  • William Marsh Rice University

    collaborator OTHER

  • M.D. Anderson Cancer Center

    lead OTHER

Principal Investigators

  • Kathleen Schmeler, MD · M.D. Anderson Cancer Center

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
25 Years
Max Age
49 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-24
Primary Completion
2028-03-30
Completion
2028-03-30

Countries

  • United States
  • Mozambique

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05372484 on ClinicalTrials.gov